Satoru Toyota

Senior Executive Officer, Head of Oncology Business Unit

Satoru Toyota

Contribution to society on a global-scale

Contribution to society on a global-scale

Since 1981, cancer has been the leading cause of death in Japan. According to statistics a total of 374,000 people died of cancer in 2016. It is estimated that in Japan today, one in two people will be affected with cancer, and one in three will die from it. Cancer has become the national disease.
As professionals and specialists of clinical research and development in oncology, Linical has contributed to society through new drug development, by supporting clinical development efforts in the area of oncology in Japan, engaging in numerous cancer-related clinical trials (solid cancers, blood cancers, supportive care), starting from Phase I trials. Through a collaboration between our Oncology Business Unit and Global Development Business Unit and in partnership with our overseas subsidiaries, we have expanded our clinical development services from only Japan to overseas markets. Thus, Linical can now make a global-scale contribution in the area of oncology. In 2016 we created the Linical “Oncology” symbol mark, using the Japanese national flag (Hinomaru), a globe, and the colors of Linical as design motifs, to visually express a global-scale contribution to oncology as a Japan-Headquartered global CRO. It is our sincere wish that Linical’s “Oncology” brand will penetrate not just Japan, but also worldwide.

Think of Linical when thinking of oncology, think of oncology when thinking of Linical

Think of Linical when thinking of oncology, think of oncology when thinking of Linical

To handle the well-known difficulties of clinical development work in oncology, Linical has invested a great deal of effort in personnel development in this area of expertise. In 2013 we set up a CRA (Clinical Research Associate) certification system in oncology, as part of our efforts to train large numbers of oncology specialists to meet clinical development needs. Everybody involved in oncology at Linical is committed to developing the brand, so that people will instantly think of Linical when they think of oncology, and conversely think of oncology when they think of Linical. So please feel free to consult with us for any of your oncology-related clinical development needs and requirements.